ONCY
Oncolytics Biotech·NASDAQ
--
--(--)
--
--(--)
1.78 / 10
Underperform
Technical assessment is poor, scoring 1.78/10 (Underperform). All three examined candlesticks—Long Upper Shadow, Marubozu White, Piercing Pattern—show bearish bias, with low win rates and negative average returns. No bullish signals appear, indicating weak momentum.
Analysis Checks(0/3)
Long Upper Shadow
Score1/10
Win Rate36.17%
Hist. Signals47
Avg Return-0.03%
Score1/10
Win Rate36.17%
Hist. Signals47
Avg Return-0.03%
Marubozu White
Score3.35/10
Win Rate44.44%
Hist. Signals18
Avg Return1.58%
Score3.35/10
Win Rate44.44%
Hist. Signals18
Avg Return1.58%
Piercing Pattern
Score1/10
Win Rate0.00%
Hist. Signals2
Avg Return-7.26%
Score1/10
Win Rate0.00%
Hist. Signals2
Avg Return-7.26%
Long Upper Shadow
Score1/10
Win Rate36.17%
Hist. Signals47
Avg Return-0.03%
Score1/10
Win Rate36.17%
Hist. Signals47
Avg Return-0.03%
Piercing Pattern
Score1/10
Win Rate0.00%
Hist. Signals2
Avg Return-7.26%
Score1/10
Win Rate0.00%
Hist. Signals2
Avg Return-7.26%
Marubozu White
Score3.35/10
Win Rate44.44%
Hist. Signals18
Avg Return1.58%
Score3.35/10
Win Rate44.44%
Hist. Signals18
Avg Return1.58%
What is the current technical signals for ONCY?
- ONCY presents a Underperform setup with a Technical Score of 1.78/10. Key technical indicators highlight an RSI of 32.32 and a MACD of -0.04, with the trend anchored by the 50-Day SMA at 1.00. Traders should monitor key support at 0.80 and resistance at 0.90.
